… Treatment outcomes for pediatric patients with acute myeloid leukemia (AML) have continued
to lag behind outcomes reported for children with acute lymphoblastic leukemia (ALL), in …

… This review reports about the main steps of development in pediatric acute myeloid
leukemia (AML) concerning diagnostics, treatment, risk groups, and outcomes. Finally, a …

… Pediatric acute myeloid leukemia is a rare and … current WHO classification of acute myeloid
leukemia, where there … an updated review of cytogenetics in pediatric AML, describing well-…

Introduction: Pediatric relapsed acute myeloid leukemia (AML) remains lethal in the majority
of cases, despite intensive therapy. Randomized trials are largely lacking, and the main …

Acute myeloid leukemias (AML) are characterized by mutations of tumor suppressor and
oncogenes, involving distinct genes in adults and children. While certain mutations have been …

… of the genetic lesions driving pediatric acute myeloid leukemia (AML), … or exclusively occur
in pediatric patients and molecular … faced to faithfully model pediatric acute leukemia in mice. …

The relapse rate for children with acute myeloid leukemia (AML) remains high despite
advancements in risk classification, multi-agent chemotherapy intensification, stem cell …

… Recent advances in the genetic understanding of acute myeloid leukemia (AML) have
improved clinical outcomes in pediatric patients. However, ∼40% of patients with pediatric AML …

Further incorporation of genomic and molecular data in pediatric AML will allow for additional
refinements in risk stratification to enable the tailoring of treatment intensity. These data will …

Introduction: Survival rates of pediatric acute myeloid leukemia (AML) in low- and middle-income
countries (LMICs) seem extremely poor, and the available literature on the matter is …